Tesla implements Grok AI chatbot into vehicles
Grok, an artificial intelligence system developed by Tesla CEO Elon Musk, is now available to use with the latest software update, according to emails sent to Tesla owners Monday. Tesla posted a demo video on X of what the Grok integration would look like with the user voice command.
Tesla announced on social media Saturday that it would roll out the Grok tool for its vehicles in the United States. The automaker said vehicle owners do not need a Grok subscription to enable the chatbot inside the car.
However, not every Tesla owner will be able to have Grok available to them. The AI chatbot will be available to vehicles delivered on or after July 12 or meet the following criteria, according to Tesla.
An AMD processor
A Model S, Model 3, Model X, Model Y or Cybertruck
Vehicle software version 2025.26
Premium Connectivity or Wi-Fi connection
This Tesla vehicle continues dominance in CA sales for third straight year
Tesla robotaxi service coming to Bay Area 'in a month or two,' according to Musk
Emails were sent to Tesla owners on Monday, informing them that their vehicle's latest software update will give them the ability to use the AI system. 'Just ask AI,' the email read.
'Press and hold the voice button on your Tesla vehicle's steering wheel and start talking. Ask Grok for news headlines, information on a topic you're curious about or a story for your kids where they're the main characters,' Tesla wrote in the email. 'To enable, open App launcher on your vehicle's touchscreen and tap Grok.
The email sent to Tesla owners comes on the same day Grok landed a nine-figure deal with the United States Department of Defense (DOD). The federal agency's contact with the AI chatbot is worth $200 million. The DOD also awarded competitors, such as OpenAI and Google, a similar contract.
Grok is a Musk-backed artificial intelligence tool that is widely seen on his social media app X. Grok's X account has more than 5 million followers.
'Grok is your AI companion, an advanced artificial intelligence built by xAI and now, is available in Tesla vehicles,' Tesla said on its website. 'Grok is designed to deliver accurate and insightful responses to questions of a wide range.'
More information about Grok and its integration into Tesla vehicles can be viewed on the automaker's website.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
17 minutes ago
- Business Insider
AMD Stock Rally Is ‘Empty Calories,' Says Citi's Top Analyst
Citi's top analyst, Christopher Danely, calls the recent rally in AMD stock (AMD) 'empty calories' because he believes the chip ban can be reinstated at any time. Yesterday, Advanced Micro Devices rallied 6.4% after President Donald Trump lifted the ban on export of artificial intelligence (AI) chips to China. The news also boosted shares of major semiconductor companies, including Nvidia (NVDA), which rose 4% to reach a new all-time high of $172.40. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Danely has a 'Hold' rating on AMD stock and a price target of $145, which implies 6.8% downside potential from current levels. Danely ranks #588 out of 9,861 analysts tracked on TipRanks. He boasts a 66% success rate and an average return per rating of 11.40%. Here's Why Citi Is Skeptical About the AI Ban Reversal The easing of export restrictions means AMD can now resume shipments of its MI308 AI chips to China. The White House had previously imposed a ban on the export of advanced AI chips to China due to national security concerns. Notably, AMD was expected to take an $800 million hit from the ban, while Nvidia faced a larger $5.5 billion impact. However, the situation has changed following the easing of trade tensions between the U.S. and China. Danely has a rather skeptical view on the news. He noted that the resumption of MI308 chip sales to China is 'not sustainable' as they could be banned again. The U.S.-China trade relations remain fragile, and even a minor incident could prompt substantial policy shifts. Having said that, Danely believes that the Trump administration's $70 billion investment in Pennsylvania for AI and energy could be highly beneficial for chipmakers, including AMD, NVDA, Broadcom (AVGO), and Micron (MU). AMD Is Positioning as a Serious Rival to Nvidia For years, AMD has been seen as secondary to Nvidia, with the latter's advanced AI chips and GPUs (Graphics Processing Units) commanding global attention. However, AMD is rapidly advancing with its own chip innovations to compete more effectively with Nvidia. Recently, AMD launched its new line of MI350 AI chips, which are expected to be nearly 30% cheaper than Nvidia's comparable chips. Also, AMD's MI355X features high-bandwidth memory (HBM), which is reportedly three times that offered by Nvidia's Blackwell B200. Is AMD a Good Stock to Buy? Despite the current optimism surrounding Advanced Micro Devices, analysts remain divided about its long-term outlook. On TipRanks, AMD stock has a Moderate Buy consensus rating based on 25 Buys and 10 Hold ratings. Also, the average AMD price target of $135.97 implies 12.6% downside potential from current levels. Year-to-date, AMD stock has gained nearly 29%.
Business Insider
17 minutes ago
- Business Insider
Evercore Sees Major Revenue Upside for AMD after Trump Lifts China AI Chip Ban
Investment firm Evercore believes that chipmaker Advanced Micro Devices (AMD) could see upside to its 2025 revenue estimates after the company announced it will resume shipments of its MI308X chips to China. Indeed, the U.S. Commerce Department has confirmed that AMD's license applications for these chips are now moving forward for review. Once approved, AMD plans to restart shipments and provide more details during its August 5 earnings call, according to Evercore. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. As a result, the firm's analysts, led by five-star-rated Mark Lipacis, anticipate that this will result in a near-term revenue boost of $700 million and a potential $1.5 billion gain in 2025. This is because AMD had previously estimated that export restrictions would lower second-quarter revenue by about $700 million and reduce 2025 revenue by $1.5 billion. It is worth mentioning that Evercore currently expects AMD's GPU revenue for 2025 to be around $6 billion, so restoring access to the Chinese market could be a major help. The analysts also noted that this could improve AMD's profit margins. In April, AMD projected an $800 million write-down due to unsold inventory and supplier agreements, which pushed Q2 gross margin guidance down to 43% from 54%. While it's unclear if the full write-down was booked in Q2, Evercore believes that the MI308X has better margins than AMD's other GPUs. Therefore, if shipments pick up again, it could provide a solid boost to the company's profitability. Is AMD a Buy, Sell, or Hold? Overall, analysts have a Moderate Buy consensus rating on AMD stock based on 25 Buys, 10 Holds, and zero Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average AMD price target of $135.97 per share implies 12.6% downside risk.
Yahoo
17 minutes ago
- Yahoo
Simulations Plus Sees Weaker Demand Persist, Outlook Softens
Simulations Plus Inc. (NASDAQ:SLP) shares declined on Tuesday following the release of its third-quarter 2025 earnings report. The company reported sales of $20.4 million, representing a 10% year-over-year increase, but this fell short of the consensus estimate of $20.9 million. This miss followed preliminary third-quarter sales figures released in June, which were already lower than expectations at $19 million to $20 million, compared to a consensus of $22.78 the revenue miss, Simulations Plus reported adjusted earnings of 45 cents per share, compared to 27 cents a year ago. Revenue breakdown showed a 6% increase in software revenue to $12.6 million and a 17% increase in services revenue to $7.7 million. The company's gross profit stood at $13.0 million, achieving a 64% margin. However, the quarter saw a substantial net loss of $67.3 million, resulting in a loss per share of $3.35. This was primarily due to a non-cash impairment charge of $77.2 million, contrasting sharply with a net income of $3.1 million and diluted EPS of $0.15 in the prior year. Adjusted EBITDA was $7.4 million, representing 37% of total revenue, up from $5.6 million (30% of total revenue) in the same period last year. Looking ahead, Simulations Plus revised its fiscal 2025 adjusted earnings guidance to $0.93 to $1.06, down from the previous guidance of $1.07 to $1.20. View more earnings on SLP Similarly, the company's fiscal 2025 sales forecast was adjusted in June to $76 million to $80 million, a reduction from the prior guidance of $90 million to $93 million and below the consensus of $82.9 million. The anticipated adjusted EBITDA margin for fiscal 2025 also saw a downward revision, now expected to be between 23% and 27%, compared to the earlier guidance of 31% to 33%. In June, Simulations Plus initiated a restructuring of its operations, including workforce reductions and cost-cutting measures, aimed at improving operational efficiency and reducing expenses. William Blair analysts noted that the company's outlook remains unchanged since June. They attribute the ongoing cautious spending by biopharma clients to uncertainties surrounding future funding, drug pricing, and potential tariffs, leading to budget cuts, project cancellations, and work postponements. Analyst Max Smock highlighted, 'While the software business remains somewhat resilient (expectation for 5% to 9% organic segment growth in fiscal 2025), we have begun to see some signs of potential softening as we head into fiscal 2026...' In response to the challenging market, KeyBanc downgraded Simulations Plus from Overweight to Sector Weight. Analyst Scott Schoenhaus commented, 'While we believe these challenges affect SLP more sharply given its customer concentration and biotech exposure, we also thought there would be opportunities with the most recent Proficiency acquisition that gave us hope that organic revenue growth could re-accelerate toward high-single digits next year (FY26) off easier comps.' KeyBanc anticipates continued weak customer demand in the near to mid-term, with no clear signs of a biotech market rebound. This makes predicting a recovery difficult and a higher valuation hard to justify, prompting the firm to significantly cut its estimates and lower its valuation target to account for these risks and uncertainties. Price Action: SLP stock is trading lower by 25% to $13.10 at last check Tuesday. Read Next:Latest Ratings for SLP Date Firm Action From To Oct 2021 Craig-Hallum Upgrades Hold Buy Jul 2021 Raymond James Maintains Outperform Jan 2021 Craig-Hallum Downgrades Buy Hold View More Analyst Ratings for SLP View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? SIMULATIONS PLUS (SLP): Free Stock Analysis Report This article Simulations Plus Sees Weaker Demand Persist, Outlook Softens originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
